Ziping  Luo net worth and biography

Ziping Luo Biography and Net Worth

Mary Z. Luo, Ph.D. has served as Chief Operating Officer for Amphastar Pharmaceuticals, Inc. and Chairman of the Board of Directors since its inception in 1996. She has also served as a Chief Scientist since 2005 and Corporate Secretary from 1996 through April 2004. As co-founder of both Amphastar Pharmaceuticals, Inc. and APCL, Dr. Luo has over 30 years of academic and practical experience in the field of chemistry. She provides scientific leadership through her research and activities in technology transfer, regulatory submission, intellectual property, clinical research, recruitment, and training. Dr. Luo is a professor emeritus of chemistry at California State Polytechnic University, Pomona and is named as the inventor on several U.S. and foreign patents. She received a Ph.D. in Chemistry from Princeton University and was a Post Doctoral Research Associate at the California Institute of Technology.

How old is Ziping Luo?

Dr. Luo is currently 74 years old. There are 4 older executives and no younger executives at Amphastar Pharmaceuticals. The oldest executive at Amphastar Pharmaceuticals is Dr. Yongfeng Zhang Ph.D., Co-Founder, President, CEO, Chief Scientific Officer & Director, who is 77 years old. Learn More on Ziping Luo's age.

How do I contact Ziping Luo?

The corporate mailing address for Dr. Luo and other Amphastar Pharmaceuticals executives is 11570 SIXTH STREET, RANCHO CUCAMONGA CA, 91730. Amphastar Pharmaceuticals can also be reached via phone at (909) 980-9484 and via email at [email protected]. Learn More on Ziping Luo's contact information.

Has Ziping Luo been buying or selling shares of Amphastar Pharmaceuticals?

Ziping Luo has not been actively trading shares of Amphastar Pharmaceuticals during the last ninety days. Learn More on Ziping Luo's trading history.

Who are Amphastar Pharmaceuticals' active insiders?

Amphastar Pharmaceuticals' insider roster includes Diane Gerst (Director), Richard Koo (Director), Howard Lee (Director), Yakob Liawatidewi (EVP), Mary Luo (COO), Ziping Luo (Chairman), William Peters (CFO), Floyd Petersen (Director), Richard Prins (Director), Michael Zasloff (Director), Jack Zhang (CEO), Yongfeng Zhang (Co-Founder), and Rong Zhou (EVP). Learn More on Amphastar Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Amphastar Pharmaceuticals?

In the last year, insiders at the sold shares 33 times. They sold a total of 551,742 shares worth more than $29,081,251.11. The most recent insider tranaction occured on March, 5th when Director Michael A Zasloff sold 12,500 shares worth more than $589,750.00. Insiders at Amphastar Pharmaceuticals own 27.8% of the company. Learn More about insider trades at Amphastar Pharmaceuticals.

Information on this page was last updated on 3/5/2024.

Ziping Luo Insider Trading History at Amphastar Pharmaceuticals

See Full Table

Ziping Luo Buying and Selling Activity at Amphastar Pharmaceuticals

This chart shows Dr. Ziping Luo's buying and selling at Amphastar Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amphastar Pharmaceuticals Company Overview

Amphastar Pharmaceuticals logo
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Read More

Today's Range

Now: $43.52
Low: $43.05
High: $43.87

50 Day Range

MA: $50.40
Low: $42.85
High: $56.43

2 Week Range

Now: $43.52
Low: $35.62
High: $67.66

Volume

419,338 shs

Average Volume

491,162 shs

Market Capitalization

$2.09 billion

P/E Ratio

16.87

Dividend Yield

N/A

Beta

0.85